DR LAL PATHLABS
|
DR LAL PATHLABS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹84 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity - Authorised | ₹108 Cr | ₹108 Cr | ₹108 Cr | ₹108 Cr | ₹108 Cr |
| Equity - Issued | ₹84 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity Paid Up | ₹84 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹57 Cr | ₹51 Cr | ₹58 Cr | ₹58 Cr | ₹40 Cr |
| Total Reserves | ₹2,032 Cr | ₹1,715 Cr | ₹1,525 Cr | ₹1,360 Cr | ₹1,122 Cr |
| Securities Premium | ₹125 Cr | ₹105 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr |
| Capital Reserves | ₹-79 Cr | ₹-79 Cr | ₹-11 Cr | ₹-11 Cr | ₹-3.30 Cr |
| Profit & Loss Account Balance | ₹1,860 Cr | ₹1,577 Cr | ₹1,351 Cr | ₹1,210 Cr | ₹981 Cr |
| General Reserves | ₹145 Cr | ₹126 Cr | ₹102 Cr | ₹84 Cr | ₹71 Cr |
| Other Reserves | ₹-19 Cr | ₹-14 Cr | ₹-11 Cr | ₹-16 Cr | ₹-20 Cr |
| Reserve excluding Revaluation Reserve | ₹2,032 Cr | ₹1,715 Cr | ₹1,525 Cr | ₹1,360 Cr | ₹1,122 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹2,173 Cr | ₹1,849 Cr | ₹1,666 Cr | ₹1,502 Cr | ₹1,245 Cr |
| Minority Interest | ₹34 Cr | ₹36 Cr | ₹33 Cr | ₹35 Cr | ₹31 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | ₹83 Cr | ₹167 Cr | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | ₹167 Cr | ₹250 Cr | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | ₹-83 Cr | ₹-83 Cr | - |
| Unsecured Loans | - | - | - | ₹0.13 Cr | ₹0.12 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | ₹0.13 Cr | ₹0.12 Cr |
| Deferred Tax Assets / Liabilities | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr | ₹-27 Cr |
| Deferred Tax Assets | ₹88 Cr | ₹45 Cr | ₹40 Cr | ₹38 Cr | ₹31 Cr |
| Deferred Tax Liability | ₹4.52 Cr | ₹2.39 Cr | ₹2.94 Cr | ₹5.03 Cr | ₹3.52 Cr |
| Other Long Term Liabilities | ₹103 Cr | ₹103 Cr | ₹130 Cr | ₹139 Cr | ₹110 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹1.95 Cr | ₹1.61 Cr | - | - | - |
| Total Non-Current Liabilities | ₹21 Cr | ₹62 Cr | ₹176 Cr | ₹273 Cr | ₹83 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹199 Cr | ₹187 Cr | ₹156 Cr | ₹147 Cr | ₹144 Cr |
| Sundry Creditors | ₹199 Cr | ₹187 Cr | ₹156 Cr | ₹147 Cr | ₹144 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹155 Cr | ₹227 Cr | ₹214 Cr | ₹227 Cr | ₹108 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹20 Cr | ₹21 Cr | ₹20 Cr | ₹21 Cr | ₹18 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | ₹0.14 Cr | ₹0.14 Cr |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹135 Cr | ₹206 Cr | ₹194 Cr | ₹206 Cr | ₹90 Cr |
| Short Term Borrowings | - | - | ₹70 Cr | ₹95 Cr | - |
| Secured ST Loans repayable on Demands | - | - | ₹70 Cr | ₹95 Cr | - |
| Working Capital Loans- Sec | - | - | ₹70 Cr | ₹95 Cr | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | ₹-70 Cr | ₹-95 Cr | - |
| Short Term Provisions | ₹49 Cr | ₹50 Cr | ₹30 Cr | ₹30 Cr | ₹22 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹14 Cr | ₹13 Cr | ₹0.50 Cr | ₹3.16 Cr | ₹4.94 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹35 Cr | ₹36 Cr | ₹29 Cr | ₹27 Cr | ₹17 Cr |
| Total Current Liabilities | ₹402 Cr | ₹464 Cr | ₹470 Cr | ₹500 Cr | ₹274 Cr |
| Total Liabilities | ₹2,630 Cr | ₹2,411 Cr | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr |
| ASSETS | |||||
| Gross Block | ₹1,904 Cr | ₹1,828 Cr | ₹1,807 Cr | ₹1,726 Cr | ₹684 Cr |
| Less: Accumulated Depreciation | ₹769 Cr | ₹635 Cr | ₹502 Cr | ₹357 Cr | ₹236 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,135 Cr | ₹1,194 Cr | ₹1,305 Cr | ₹1,369 Cr | ₹447 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹3.48 Cr | ₹3.95 Cr | ₹2.97 Cr | ₹14 Cr | ₹6.13 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹27 Cr | ₹31 Cr | ₹35 Cr | ₹40 Cr | ₹27 Cr |
| Other Non Current Assets | ₹68 Cr | ₹20 Cr | ₹27 Cr | ₹11 Cr | ₹4.13 Cr |
| Total Non-Current Assets | ₹1,267 Cr | ₹1,284 Cr | ₹1,372 Cr | ₹1,435 Cr | ₹488 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹327 Cr | ₹114 Cr | ₹150 Cr | ₹65 Cr | ₹59 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹327 Cr | ₹114 Cr | ₹150 Cr | ₹65 Cr | ₹59 Cr |
| Inventories | ₹36 Cr | ₹37 Cr | ₹34 Cr | ₹53 Cr | ₹43 Cr |
| Raw Materials | - | - | - | - | - |
| Work-in Progress | - | - | - | - | - |
| Finished Goods | - | - | - | - | - |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹36 Cr | ₹37 Cr | ₹34 Cr | ₹52 Cr | ₹42 Cr |
| Other Inventory | ₹0.05 Cr | ₹0.03 Cr | ₹0.22 Cr | ₹0.82 Cr | ₹0.85 Cr |
| Sundry Debtors | ₹88 Cr | ₹77 Cr | ₹71 Cr | ₹85 Cr | ₹67 Cr |
| Debtors more than Six months | ₹115 Cr | ₹107 Cr | ₹32 Cr | ₹31 Cr | ₹11 Cr |
| Debtors Others | ₹2.38 Cr | ₹2.08 Cr | ₹73 Cr | ₹83 Cr | ₹77 Cr |
| Cash and Bank | ₹839 Cr | ₹830 Cr | ₹665 Cr | ₹618 Cr | ₹926 Cr |
| Cash in hand | ₹2.57 Cr | ₹1.83 Cr | ₹1.18 Cr | ₹1.42 Cr | ₹1.49 Cr |
| Balances at Bank | ₹836 Cr | ₹828 Cr | ₹664 Cr | ₹616 Cr | ₹925 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹51 Cr | ₹48 Cr | ₹34 Cr | ₹34 Cr | ₹32 Cr |
| Interest accrued on Investments | ₹35 Cr | ₹31 Cr | ₹22 Cr | ₹20 Cr | ₹24 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹14 Cr | ₹8.17 Cr |
| Other current_assets | - | - | - | - | - |
| Short Term Loans and Advances | ₹23 Cr | ₹20 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr |
| Advances recoverable in cash or in kind | ₹5.49 Cr | ₹2.64 Cr | ₹2.85 Cr | ₹4.19 Cr | ₹3.14 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Total Current Assets | ₹1,364 Cr | ₹1,127 Cr | ₹973 Cr | ₹875 Cr | ₹1,145 Cr |
| Net Current Assets (Including Current Investments) | ₹961 Cr | ₹663 Cr | ₹503 Cr | ₹375 Cr | ₹871 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,630 Cr | ₹2,411 Cr | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr |
| Contingent Liabilities | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
| Total Debt | - | ₹83 Cr | ₹237 Cr | ₹346 Cr | ₹0.12 Cr |
| Book Value | - | 215.40 | 192.88 | 173.17 | 144.61 |
| Adjusted Book Value | 253.14 | 215.40 | 192.88 | 173.17 | 144.61 |
Compare Balance Sheet of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹27,248.8 Cr | 5.3% | 2.7% | 2.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,510.0 Cr | -0.7% | 5.1% | 10% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹111,467.0 Cr | -2.8% | 3.1% | 15.3% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹77,787.1 Cr | -2.6% | 4.1% | 70.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,492.7 Cr | 0.6% | 3% | 42.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹34,290.9 Cr | -5.9% | -2.3% | 22.8% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 5.3% |
2.7% |
2.6% |
| SENSEX | -0.9% |
4.6% |
5% |
You may also like the below Video Courses